Search

Your search keyword '"Rozentale B."' showing total 96 results

Search Constraints

Start Over You searched for: Author "Rozentale B." Remove constraint Author: "Rozentale B." Language english Remove constraint Language: english
96 results on '"Rozentale B."'

Search Results

1. Management of MDR-TB in HIV co-infected patients in Eastern Europe: Results from the TB:HIV study

2. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

3. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens

4. The extent of B‐cell activation and dysfunction preceding lymphoma development in HIV‐positive people†

5. Gender differences in the use of cardiovascular interventions in HIV?positive persons; the D:A:D Study

6. The present and future disease burden of hepatitis C virus infections with todayʼs treatment paradigm – volume 3

7. Historical epidemiology of hepatitis C virus (HCV) in select countries – volume 3

8. Strategies to manage hepatitis C virus infection disease burden – volume 3

9. Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA

11. Healthcare delivery for HIV-positive people with tuberculosis in Europe

15. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

20. Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort

21. Major differences in organization and availability of health care and medicines for HIV/TB coinfected patients across Europe

22. Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study

23. Long-term effectiveness of unboosted atazanavir plus abacavir/lamivudine in subjects with virological suppression : A prospective cohort study

24. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors

25. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

26. Infection-related and -unrelated malignancies, HIV and the aging population

27. Tuberculosis-related mortality in people living with HIV in Europe and Latin America: An international cohort study

28. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

29. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

30. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

31. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

32. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

33. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

34. Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients

35. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

36. A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study

37. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

38. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

39. Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

40. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

41. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens.

49. Reasons of hospitalization for HIV-positive patients in the Infectology Center of Latvia in the period from 2009 to 2011.

50. Prevention of mother-to-child transmission of HIV in Latvia, 2008-2011.

Catalog

Books, media, physical & digital resources